Advertisement

Tuesday Ratings | MARRIED AT FIRST SIGHT brings home the ratings bacon

Advertisement

Second night and the numbers tick UP.

Nine have an embarrassment of riches. A Current Affair (720,000) slams 7pm then Married At First Sight (992,000) grows its audience for night two, leaving its competition for dead. It really doesn’t matter what Botched (386,000) or Labour of Love (128,000) do because it was all over once MAFS was done…as is becoming the standard for all the networks. The post-9pm/9:30pm offerings don’t count for anything. Nine first be a sizeable margin for both primary (26.6%) & network (34.9%) shares.

Seven’s best – Home and Away (460,000) – doesn’t lift their hopes any. The Highway Patrol Special (303,000) was largely ignored, and the US dramas The Good Doctor (294,000) and The Resident (160,000) offered no support. Seven second by daylight in both primary (14.8%) & network (22.8%) shares.

The ABC started reasonably with 7:30 (503,000), and slid into mediocrity beyond that. Foreign Correspondent (390,000), Catalyst (303,000), Australia Remastered (163,000), and a repeat of QI (127,000) do nothing to help what has continued to be problematic Tuesday nights. ABC third in primary (11.5%) & fourth in network (15.6%) shares.

10 in all sorts of trouble as The Project (233,000 6:30pm; 415,000 7pm) underwhelms, dragging down The Amazing Race Australia (459,000) with it. NCIS (263,000) and NCIS: Los Angeles (221,000)–both of which used to command double this audience but only two years ago–check in however that’s about all they do. 10 all the way back in fourth in primary (11.3%) & scrapes a third in network (18.3%) shares.

Breakfast

Sunrise (262,000)
The Today Show (206,000)
ABC Breakfast (196,000 [124,000 ABC; 72,000 ABC News])

All ratings data listed is Five City Metro, overnights only.

Top 20 Overnight Metro

Top 20 Multi-Channel Shows

Overnight Network Share

Top 20 Foxtel Shows

Data © OzTAM Pty Limited 2021. The data may not be reproduced, published or communicated (electronically or in hard copy} in whole or in part, without the prior written consent of OzTAM.

Note: Program performance and ranking information subject to change when not based on final program logs. Programs with the same name on one or more primary or multichannel, are aggregated into one network figure.

Steve Molkhttps://tvblackbox.com.au/author-steve-molk/
Steve Molk is sharply focused on the business of TV in Australia across all its formats - FTA broadcast, commercial, subscription, catch up & SVOD. Based on the Central Coast of NSW he's a passionate advocate for Australian-made programming, particularly drama and comedy. He loves podcasting, gaming & watching too much TV. For all media enquiries please call or text 0401-709-405
Advertisement

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related

Podcasts

Do Channel 10’s bold claims stack up?

The CEO of Channel 7 described Channel 10’s Up Close sales reel as ‘desperate’. Is he right or was 10 pitch perfect talking to advertisers? This is TV Blackbox S05E19
Advertisment

Featured Stories

Do Channel 10’s bold claims stack up?

The CEO of Channel 7 described Channel 10’s Up Close sales reel as ‘desperate’. Is he right or was 10 pitch perfect talking to advertisers? This is TV Blackbox S05E19

Socials

3,573FansLike
390FollowersFollow
16,170FollowersFollow

ratings

latest

Romantic comedy series WELCOME TO SWEDEN arrives at SBS On Demand

Soon, Emma and Bruce are getting married - hopefully! The new season opens with a proposal, but as the weeks continue the lovebirds and their hilariously bizarre families clash over everything from opposing customs and expectations to the ultimate in-law face-off over where the nuptials should take place.

AIRDATE | Sports documentary goes behind the scenes of Olympic drug cheat MARION JONES: PRESS PAUSE

For years, Jones denied the increasing speculation that she used performance-enhancing drugs. But in October 2007, she finally admitted what so many had long suspected - that she had indeed used steroids.